≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Carcinoma in situ of liver, gallbladder and bile ducts

PheWeb

CD2_INSITU_LIVER_GALLBLADDER_BILE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D01.5&
Hospital discharge: ICD-9 2308
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D01.5&
Cause of death: ICD-9 2308
Cause of death: ICD-8 $!$

7

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

7

diagram downward connector

Check minimum number of events None

7

diagram downward connector

Include endpoints None

7

diagram downward connector
CD2_INSITU_LIVER_GALLBLADDER_BILE

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D01
Name in latin Carcinoma in situ hepatis

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 7 5 -
Unadjusted prevalence (%) 0.00 0.00 -
Mean age at first event (years) 52.64 52.80 -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_INSITU_LIVER_GALLBLADDER_BILE – Carcinoma in situ of liver, gallbladder and bile ducts
GWS hits:

Survival analyses between endpoints

↥

Plot

before Carcinoma in situ of liver, gallbladder and bile ducts
after Carcinoma in situ of liver, gallbladder and bile ducts

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Carcinoma in situ of liver, gallbladder and bile ducts

↥